Status:
COMPLETED
Effects of Gender-affirming Hormone Therapy on Transgender People
Lead Sponsor:
National Taiwan University
Conditions:
Gender Dysphoria
Eligibility:
All Genders
18+ years
Brief Summary
This prospective cohort study aims to assess the impact of gender-affirming hormone therapy (GAHT) on transgender individuals' physical, psychological, social, and quality of life aspects. Based on ge...
Detailed Description
The willingness and proportion of transgender persons diagnosed with gender dysphoria to receive gender-affirming hormone therapy (GAHT) is relatively high, so as to conform to their internal gender i...
Eligibility Criteria
Inclusion
- transgender
Exclusion
- \-
Key Trial Info
Start Date :
January 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2025
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT06022562
Start Date
January 8 2024
End Date
July 31 2025
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University, College of Medicine, School of Nursing
Taipei, Taiwan